MORE ARTICLES
- Becket Fund’s Eric Rassbach on Loffman v. CA DOE, Religious Liberty, & SchoolingNovember 27, 2024 - 10:30 am
- Pioneer Institute Statement on Vocational-Technical School AdmissionsNovember 26, 2024 - 8:00 am
- FY2026 Consensus Revenue Hearing – Forecasting of Revenues is Tricky BusinessNovember 25, 2024 - 8:00 am
- CUNY’s Carl Rollyson on William Faulkner & Southern LiteratureNovember 20, 2024 - 10:36 am
- Pioneer Institute Study Finds Massachusetts Saw Four-Fold Loss of Income to Net OutmigrationNovember 19, 2024 - 11:25 am
- Massachusetts Job Market Bears WatchingNovember 18, 2024 - 2:10 pm
- NH Gov. Chris Sununu on School ChoiceNovember 13, 2024 - 2:02 pm
- Five Reasons Why Project Labor Agreements Are Bad Public PolicyNovember 12, 2024 - 9:27 am
- Statement of Pioneer Institute on MCAS Ballot Failure and State of Education in MassachusettsNovember 6, 2024 - 2:01 pm
- Dr. Helen Baxendale on Great Hearts Classical Liberal Arts Charter SchoolsNovember 6, 2024 - 12:08 pm
Stay Connected!
Receive the latest updates in your inbox.
William & Mary’s Dr. Charles Hobson on Chief Justice John Marshall, SCOTUS, & Judicial Review
/in Featured, Podcast, US History /by Editorial StaffThis week on “The Learning Curve,” co-hosts Cara Candal and Gerard Robinson talk with Dr. Charles Hobson, a retired resident scholar at the William & Mary Law School, 26-year editor of The Papers of John Marshall, and author of The Great Chief Justice: John Marshall and the Rule of Law. Dr. Hobson shares what students should know about the longest-serving, most important chief justice in the history of the Supreme Court, and his influence on our understanding of the U.S. Constitution.
Drug Price Control: Bad Medicine for Healthcare and Region
/in Featured, Healthcare, Podcast Hubwonk /by Editorial StaffHubwonk host Joe Selvaggi talks with Dr. Bill Smith, Director of Pioneer Institute’s Life Sciences Initiative, about the impact of the Inflation Reduction Act on long-term health costs. They discuss the bill’s unintended consequences, potential effect on the region’s vibrant pharmaceutical research and development sector, and what citizens can do about it.
Massachusetts Needs a Comprehensive Performance Management Framework
/0 Comments/in Better Government, Blog, Blog: Better Government, Blog: Transparency, Blogroll, News, Transparency /by Joseph StaruskiMany states have made promoted government efficiency and effectiveness by setting goals and tracking their progress. Massachusetts tried making a performance structure, but in 2014 it was discontinued. Today, the state lacks a comprehensive structure to track progress.
The Realities Behind US Healthcare Spending
/in Blog: Healthcare, Featured, Healthcare, Life Sciences /by Gauri BinoyHealthcare policy is an all-encompassing term. It plays a role in every individual’s life; how it is curated, developed, and maintained has a significant long-term impact on the quality of life of any given community. It is critical that policymakers consistently adapt and amend healthcare policies in the ever-changing global pricing and affordability environment while providing funding support for optimal quality of care.
Cures for Patients, Not Health Plan Profits, Make Drugs Valuable
/in Featured, Life Sciences /by William SmithTo the astonishment of many observers, the Institute for Clinical and Economic Review (ICER) recently concluded that a $2.1 million gene therapy for a life-threatening blood disorder called beta thalassemia, is priced cost-effectively. The surprise was especially pleasant, given that ICER’s methodology had, in the past, displayed bias against rare disease treatments and undervalued the lives of people living with disabilities.